Researchers analyzed news reports and press releases from 50 provinces, regions and countries outside of Wuhan, China. They studied information about 181 confirmed COVID-19 cases reported between Jan. 4 and Feb. 24.
They found that the median incubation period for the virus was estimated to be 5.1 days, and that most people who develop symptoms (97.5 percent) will do so within 11.5 days of contracting the virus.
Fourteen days is the standard length of quarantine or active monitoring currently being used in the public health response to the COVID-19 outbreak in the U.S.
“Our results support current proposals for the length of quarantine or active monitoring of persons potentially exposed to SARS-CoV-2, although longer monitoring periods might be justified in extreme cases,” study authors concluded.
More articles on infection control:
Use of 2 central line catheters at once can up CLABSI risk, study shows
Here’s how a Hong Kong hospital tested 1,275 for coronavirus, and no employees got sick
58 hospitals with the nation’s best CAUTI rates
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
